10 Health Care Stocks Whale Activity In Today's Session
Novocure Is Maintained at In-Line by Evercore ISI Group
NovoCure Analyst Ratings
Evercore Maintains Novocure(NVCR.US) With Hold Rating, Cuts Target Price to $18
Novocure Price Target Lowered to $18 From $21 at Evercore ISI
Novocure to Report Third Quarter 2024 Financial Results
Even After Rising 3.2% This Past Week, NovoCure (NASDAQ:NVCR) Shareholders Are Still Down 86% Over the Past Three Years
Why NovoCure Stock Dived by 13% This Week
Wells Fargo Maintains Novocure(NVCR.US) With Buy Rating, Maintains Target Price $40
Novocure -15%, Names Ashley Cordova as CEO
Express News | Novocure Ltd - Ashley Cordova to Succeed Asaf Danziger as Novocure CEO
Express News | Novocure Ltd - Asaf Danziger to Retire as Novocure CEO at Year-End
Novocure Announces Planned CEO Transition
Novocure to Participate in 2024 Wells Fargo Healthcare Conference
Wall Street Analysts Think NovoCure (NVCR) Could Surge 35.96%: Read This Before Placing a Bet
Novocure Highlights TTFields Therapy in Treatment of Non-Small Cell Lung Cancer at 2024 World Conference on Lung Cancer
Biotech Stocks: Which Drugmakers Are Worth a Buy?
Even After Rising 8.9% This Past Week, NovoCure (NASDAQ:NVCR) Shareholders Are Still Down 86% Over the Past Three Years
New Strong Buy Stocks for August 1st
PayPal Posts Upbeat Earnings, Joins Sprouts Farmers Market, Stanley Black & Decker, Phillips 66 And Other Big Stocks Moving Higher On Tuesday